BlackRock »

Crinetics Pharmaceuticals In shares owned by BlackRock

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $335M 6.5M 51.10

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Crinetics Pharmaceuticals In

BlackRock
BlackRock
Driehaus Capital Management
Vanguard Group
T. Rowe Price Associates
EcoR1 Capital
State Street Corporation
Jennison Associates
Point72 Asset Management
Paradigm Biocapital Advisors
Henderson Group
Geode Capital Management
Perceptive Advisors
Franklin Resources
Cormorant Asset Management

View all funds holding Crinetics Pharmaceuticals In